Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension

Although angiotensin receptor blockers have different receptor binding properties no comparative studies with cardiovascular disease (CVD) end points have been performed within this class of drugs. The aim of this study was to test the hypothesis that there are blood pressure independent CVD-risk di...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kjeldsen, S E, Stålhammar, J, Hasvold, P, Bodegard, J, Olsson, U, Russell, D
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2010
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2834374/
https://ncbi.nlm.nih.gov/pubmed/19890371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jhh.2009.77
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items